Abstract

Micro-dosing of fine cohesive powders is the key technology in additive manufacturing and especially in high-potency active pharmaceutical ingredients (HPAPI). However, high accuracy micro-dosing (<5 mg) of fine cohesive powder is less trivial and still remains a challenge because it is difficult to eliminate the aggregation phenomena caused by the strong interparticle cohesive forces (in small capillaries). This paper presents a novel micro-dose method of fine cohesive powders via a pulse inertia force system. A piezoelectric actuator is used to provide a high enough pulse inertia force for a tapered glass nozzle and drive powder particles in the nozzle to be discharged from the nozzle orifice with the help of particle self-gravity. The nozzles with outlet diameters in the range of 100–2000 µm were fabricated via a glass heating process. The α-lactose monohydrate powder is used as the micro-dosing powder. The influences of the tapered nozzle outlet diameter, amplitude of the applied pulse voltage, and angle of the nozzle axis on micro-dosing mass are researched. The minimum mean dose mass is 0.6 mg for a single pulse inertia force. The coefficient of variation of dose mass, which represents the micro-dosing stability, can be controlled below 5% when the dose mass is relatively small.

Highlights

  • Micro-dosing of fine powders can be applied in additive manufacturing [1] and in the pharmaceutical industries, typically, in selective laser sintering (SLS) [2], three-dimensional printing (3DP) [3], and high-potency active pharmaceutical ingredients (HPAPI)

  • We developed a simple fine cohesive powder micro-dosing approach and the powder is discharged from a tapered glass capillary actuated by a hollow piezoelectric transducer (PZT) stack without any complex structure

  • This paper presents a novel method for micro-doses of fine cohesive powders actuated by pulse inertia force

Read more

Summary

Introduction

Micro-dosing of fine powders can be applied in additive manufacturing [1] and in the pharmaceutical industries, typically, in selective laser sintering (SLS) [2], three-dimensional printing (3DP) [3], and high-potency active pharmaceutical ingredients (HPAPI). In HPAPI [4], the dosing of only a few mg (or less) of active pharmaceutical ingredient (API) powders in a drug product is needed. These API powders (e.g., a-lactose monohydrate powder) are made of very fine and sticky particles [5]. The interparticle cohesive forces begin to play a major role in the bulk powder behavior. The strong interparticle adhesion forces cause the formation of aggregates [6,7], which may cause micro-dosing process unstability and inaccuracy

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call